Carmot Therapeutics competitorsClear all

Carmot Therapeutics's top competitors include ImCheck Therapeutics, AB2 Bio, MedDay and Pandion Therapeutics.
Carmot Therapeutics
Carmot Therapeutics
Carmot Therapeutics is a biotech company focused on the discovery of innovative drugs for the treatment of metabolic diseases, cancer, and inflammation.
ImCheck Therapeutics
ImCheck Therapeutics
ImCheck Therapeutics is a biotech company developing the next generation of immune checkpoint modulators .
AB2 Bio
AB2 Bio
AB2 Bio is developing drugs that will not only treat the symptoms but also target the underlying causes of inflammation based diseases.
MedDay
MedDay
MedDay is a biotechnology company specializing in therapeutics for the treatment of neuro-metabolic diseases.
Pandion Therapeutics
Pandion Therapeutics
Pandion Therapeutics is a biotechnology company developing bispecific antibody therapeutics to achieve localized immunomodulation at the site of disease for durable, tissue-specific treatment of patients with autoimmune and inflammatory disease and organ transplants.
Founding Date
Founding Date
2008
Founding Date
2015
Founding Date
2010
Founding Date
2011
Founding Date
2017
Type
Type
Private
Type
Private
Type
Private
Type
Private
Type
Private
Tags
Locations
Locations
Berkeley, US HQ
Locations
Marseille, FR HQ
Locations
Lausanne, CH HQ
Locations
Paris, FR HQ
Locations
Cambridge, US HQ
Employees
Employees
166% decrease
Employees
30
Employees
244% increase
Employees
881% decrease
Employees
356% increase
Twitter followers
Twitter followers
N/A
Twitter followers
199
Twitter followers
N/A
Twitter followers
215
Twitter followers
133
Number of tweets (last 30 days)
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
2
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
1
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
50%
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
100%
Alexa Website Rank
Alexa Website Rank
N/A
Alexa Website Rank
561836
Alexa Website Rank
633184
Alexa Website Rank
284794
Alexa Website Rank
713911

Funding

Latest funding round
Latest funding round
$ 15m (over 1 year ago)
Latest funding round
$ 1.1m (almost 2 years ago)
Latest funding round
N/A
Latest funding round
$ 38.5m (over 3 years ago)
Latest funding round
$ 58m (over 1 year ago)
Total funding raised
Total funding raised
$ 27.8m
Total funding raised
$ 22.9m
Total funding raised
N/A
Total funding raised
$ 48.9m
Total funding raised
$ 58m
For sources of this data, please see the company profile

View company profiles

ImCheck Therapeutics
HQ
Marseille, FR
Employees
30

ImCheck Therapeutics is a biotech company developing the next generation of immune checkpoint modulators .

View company
AB2 Bio
HQ
Lausanne, CH
Employees
24↑ 4% increase

AB2 Bio is developing drugs that will not only treat the symptoms but also target the underlying causes of inflammation based diseases.

View company
MedDay
HQ
Paris, FR
Employees
88↓ 1% decrease

MedDay is a biotechnology company specializing in therapeutics for the treatment of neuro-metabolic diseases.

View company
Pandion Therapeutics
HQ
Cambridge, US
Employees
35↑ 6% increase

Pandion Therapeutics is a biotechnology company developing bispecific antibody therapeutics to achieve localized immunomodulation at the site of disease for durable, tissue-specific treatment of patients with autoimmune and inflammatory disease and organ transplants.

View company